Status:
UNKNOWN
Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Diabetes Mellitus
Coronavirus Infection
Eligibility:
All Genders
18+ years
Brief Summary
The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the COVID-19 (Coronavirus Disease-2019) in December 2019 has led to an unprecedented international health situation...
Eligibility Criteria
Inclusion
- Adult patients
- Patient with diabetes known for at least 6 months before inclusion
- Patient followed by a specialist physician from the University Hospital of Nancy for routine care within the 6 months prior to the lockdown.
- Patient who was assessed for prioritization of care following the end of the lockdown by the department of endocrinology, diabetology and nutrition
Exclusion
- Subjects opposed to the use of their data
- Minors, adults under guardianship, protected persons
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT04485351
Start Date
July 1 2020
End Date
September 1 2020
Last Update
July 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Regional Hospital of Nancy
Nancy, France